Dr. Toshio Inui
CEO of the Saisei Mirai Clinic group
Medical Doctor, PhD
Kagoshima University, visiting professor
M.D., Ph. D
Specialized in a Internal medicine , Gerontology , Dementia, Kampo and a Japanese sports doctor.
Graduated from Kyoto Prefectural University of Medicine in 1978.
At the age of 33, after gaining experience working in the internal medicine department at a general hospital as a physician, he established Inui Clinic for the treatment of internal diseases.
He soon came to develop a reputation for careful and heartwarming medical examinations which made him popular with patients.
After the loss of his father due to cancer, he came to realize the limitations of conventional therapies for cancer such as surgery, chemothearapy anticancer drugs and radiation therapy, and he started his new practice specializing in immunotherapy for cancer. He also changed his clinic name to Inui Immunotherapy Cancer Clinic.
In 2010 he established Saisei Mirai Kobe Clinic in Kobe Japan.
Currently the clinic is cooperating with medical institutions in Japan as well as overseas, and carrying out research and development of new immunotherapies, such as GcMAF, autologous cancer vaccines, and hyper T/NK cell therapy.
|Graduated from Kyoto Prefectural University of Medicine.
|University Hospital, Kyoto Prefectural University of Medicine. Worked in the first course for internal medicine.
|Japanese Red Cross Kyoto Daini Hospital. Worked in the emergency medical care center.
|Japanese Red Cross Kyoto Daini Hospital. Worked in internal medicine.
|Opened Inui Cancer Immunotherapy Clinic in Osaka Japan.
|Incorporated the medical institution Saisei Mirai.
Inaugurated as the chairman of the board of directors.
|Opened Keihan Saisei Medical Center in Osaka Japan.
|Opened Saisei Mirai Kobe Clinic, Kobe Japan.
|Began developing Second Generation High Dose GcMAF in collaboration with Tokushima University in Japan.
|Began production of 2nd Generation High Dose GcMAF in our Cell Processing Center (CPC) followed by clinical use for patients.
|Opened Saisei Mirai iTokyo Clinic, Tokyo Japan.
|Opened Saisei Mirai Keihan Clinic, Osaka Japan.
|Kyoto Prefectural University of Medicine, serve as a visiting professor.
|Ritsumeikan University, serve as a visiting professor.
|Kagoshima University, serve as a visiting professor.
Graduated from First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) in 2017.
She worked in the biggest in Russia federal multi-profile medical center FNCC FMBA of RUSSIA as an allergist-immunologist. She did various allergy tests, supervised patients with different types of allergies and immunological problems, conducted research on patients with anaphylaxis and vaccinated patients with rabies vaccine to prevent rabies caused by a dog bite.
In 2019 Dr. Ekaterina joined Saisei Mirai Groups and in 2020 Saisei Mirai company was opened in Moscow and oral GcMAF was registered on the territory of the customs union – Russia, Kazakhstan and Belarus.
The pandemic of a new coronavirus infection changed the world and medical situation in each country.
During that time In 2020 Dr. Ekaterina extended her knowledge in medicine and post-graduated in genetic, nutritiology and dietetic, and started to work more deeply with patients at a genetic level identifying defects and deficiencies in the body by blood testing for DNA and other laboratory tests.
Dr Yoko Uchiyama
Director of Saisei LT
Dr Kiyo Fujita